Isatuximab, lenalidomide, bortezomib and dexamethasone as induction therapy show a superior MRD negativity rate for newly diagnosed MM patients

The abscopal effect of radiotherapy and nivolumab in relapsed or refractory Hodgkin lymphoma

Lack of access to new cancer medicines in LMICs

Biomarker analysis of the NeoALTTO trial provides oncofertility insight for younger breast cancer patients

ASCO 2022: Breast cancer highlights

CheckMate 9ER: aRCC patients on nivolumab plus cabozantinib achieved deeper responses vs sunitinib

Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer

N-803-BCG combination shows promising results in BCG-unresponsive NMIBC

Diagnostic performance and survival outcome of SLNB procedure in breast cancer patients from a tertiary cancer care centre

War in Ukraine: Impacts on the Slovakian cancer care system

Inspiration Family: Challenges of the Ukrainian cancer charity on the frontline

War in Ukraine: Impacts on the Ukrainian cancer care system